GB2522188B - A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof - Google Patents

A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof

Info

Publication number
GB2522188B
GB2522188B GB1400407.1A GB201400407A GB2522188B GB 2522188 B GB2522188 B GB 2522188B GB 201400407 A GB201400407 A GB 201400407A GB 2522188 B GB2522188 B GB 2522188B
Authority
GB
United Kingdom
Prior art keywords
composition
body weight
lactobacillus reuteri
controlling body
reuteri gmnl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1400407.1A
Other versions
GB201400407D0 (en
GB2522188A (en
Inventor
Chen Yi-Hsing
Hsieh Feng-Ching
Chen Po-Yung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genmont Biotech Inc
Original Assignee
Genmont Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmont Biotech Inc filed Critical Genmont Biotech Inc
Priority to GB1400407.1A priority Critical patent/GB2522188B/en
Publication of GB201400407D0 publication Critical patent/GB201400407D0/en
Publication of GB2522188A publication Critical patent/GB2522188A/en
Application granted granted Critical
Publication of GB2522188B publication Critical patent/GB2522188B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB1400407.1A 2014-01-10 2014-01-10 A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof Active GB2522188B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1400407.1A GB2522188B (en) 2014-01-10 2014-01-10 A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1400407.1A GB2522188B (en) 2014-01-10 2014-01-10 A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof

Publications (3)

Publication Number Publication Date
GB201400407D0 GB201400407D0 (en) 2014-02-26
GB2522188A GB2522188A (en) 2015-07-22
GB2522188B true GB2522188B (en) 2016-09-21

Family

ID=50191142

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1400407.1A Active GB2522188B (en) 2014-01-10 2014-01-10 A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof

Country Status (1)

Country Link
GB (1) GB2522188B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2535177A (en) * 2015-02-11 2016-08-17 Genmont Biotech Inc Composition and use of lactobacillus reuteri GMNL-263 in decreasing blood lipid levels
BE1025428B1 (en) * 2018-01-23 2019-02-14 Omega Pharma Innovation & Development Nv FOOD SUPPLEMENT AND USE THEREOF
US20220105141A1 (en) * 2018-06-26 2022-04-07 Genmont Biotech Incorporation Lactobacillus reuteri gmnl-263 for improving hypertension and its compositions thereof
KR20220008252A (en) 2018-10-24 2022-01-20 노보자임스 에이/에스 Probiotic Supplements for Metabolic Health Containing Lactobacillus
CN114631564B (en) * 2021-12-08 2023-11-21 合肥师范学院 Sugar-reducing yoghourt and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2392340A1 (en) * 2010-06-01 2011-12-07 GenMont Biotech Inc. Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof
US20120183504A1 (en) * 2011-01-14 2012-07-19 Ying-Chen Lu Composition and use of probiotic strain gm-263 (adr-1) in treating renal fibrosis in diabetes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2392340A1 (en) * 2010-06-01 2011-12-07 GenMont Biotech Inc. Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof
US20120183504A1 (en) * 2011-01-14 2012-07-19 Ying-Chen Lu Composition and use of probiotic strain gm-263 (adr-1) in treating renal fibrosis in diabetes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Nutrition & Metabolism, Hsieh F.C., et al., Vol 10 (1), 2013, "Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats", p. 35. Available online at http://www.nutritionandmetabolism.com/content/pdf/1743-7075-10-35. *

Also Published As

Publication number Publication date
GB201400407D0 (en) 2014-02-26
GB2522188A (en) 2015-07-22

Similar Documents

Publication Publication Date Title
HK1243073A1 (en) Therapeutic compounds and uses thereof
GB201411197D0 (en) Composition and use thereof
RS62608B1 (en) Modified biological control agent and its uses
PT3018183T (en) Haloolefin-based composition and use thereof
SG11201702603RA (en) Organosilica materials and uses thereof
GB201403093D0 (en) Therapeutic compounds and their use
HUE044571T2 (en) Modified cyclopentapeptides and uses thereof
GB201401617D0 (en) Novel combination and use
GB201404470D0 (en) Therapeutic methods and materials
HK1243950A1 (en) Novel combination and use
PL3223837T3 (en) Lactobillus for use as probiotic
ZA201704105B (en) Refractories and use thereof
ZA201703976B (en) Dihydropyrimidine-2-one compounds and medicinal uses thereof
HUE059878T2 (en) Composition and pharmaceuticals for reducing localized fat and body weight and the use thereof
IL248424A0 (en) Neuro-protective agents and uses thereof
GB201403969D0 (en) Compounds for use in controlling body fat
GB2522188B (en) A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof
GB201421381D0 (en) A nematicidal composition and the use thereof
GB201418809D0 (en) Therapeutic agents and uses thereof
GB2533082C (en) A nematicidal composition and the use thereof
PT3129398T (en) New medical agents and uses thereof
GB201411196D0 (en) Composition and use thereof
GB2571646B (en) A nematicidal composition and the use thereof
PL3229772T3 (en) 6-aryl-9-glycosylpurines and use thereof
GB201417777D0 (en) Novel compounds and therapeutic uses thereof